Recent Finacing
Recent Raise
Alveolus Bio develops lung disease therapies using proprietary resMIT platform, advancing programs for COPD, BPD, pulmonary fibrosis, cystic fibrosis, and additional respiratory indications from Birmingham, AL and Cambridge, MA.
